ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:
Solutie antistress!
Construieste poduri :)
Prinde pisica neagra :)
EndoGastric Solutions, Inc. Completes Five Fully Transoral Redo-Obesity Procedures: Without Skin Incision - In As Little As 20 Minutes
EndoGastric Solutions, Inc., the
world leader in endoluminal intragastric surgery, announces the successful
reduction of the stomach pouch size after gastric bypass for obesity, using
StomaphyX(TM), a new endoluminal surgical device.
In December 2006, five StomaphyX(TM) pouch reduction procedures were
successfully performed by Dr. Jacques Himpens and Professor Michel Cremer
at Sint-Blasius Hospital in Dendermonde, Belgium. Immediately after the
procedure, x-rays showed close to a 50% reduction in pouch size and a
substantial change in pouch shape in all patients. All patients experienced
the onset of satiety and a significant change in their eating patterns,
reported that their stomachs felt similar to the four to five week period
after the original surgery, and began to lose excess weight.
"For the first time, we have been able to achieve similar near term
results as we would hope to achieve with a laparoscopic gastric
redo-procedure but through a fully trans-oral procedure," said Dr. Jacques
Himpens who has performed over 600 gastric redo-procedures and more than
6,000 bariatric procedures, making him one of the most experienced
bariatric surgeons in the world.
"We demonstrated that this procedure is possible, less invasive, and so
far after three weeks, effective," said Dr. Himpens. "All five of my
patients have lost weight, significantly altered their eating habits, and
have benefited from the incisionless aspects of this procedure. I also
believe that the reconstructed pouches will hold for them in the near
term."
"The StomaphyX procedure can be performed in as little as 15 to 20
minutes," continued Dr. Himpens. "Because the procedure is performed
transorally, patients are able to return to their normal routines much
faster than if they underwent open or laparoscopic surgery. I know that one
patient was able to return to her job as a hairdresser the next day. This
was especially important to her because she did not want to miss a single
appointment during the busy holiday rush."
According to Himpens, failure to maintain adequate weight loss after
gastric bypass has been reported to be as high as 25-30% as many procedures
start to fail three years after surgery. In these cases, surgical redo-
procedures are often required.
"This breakthrough procedure is important for the future of both
bariatric surgery and gastroenterology since we are dealing with an
extremely fragile patient population who often cannot undergo a second or
third surgical procedure," said Professor Michel Cremer. "When these
patients return for a follow up visit and have regained their weight, they
are devastated from a psychological standpoint and, until now, they were
faced with the prospect of yet another serious surgery or the risk of
becoming morbidly obese again. StomaphyX has the potential to reach many of
these patients and provide a minimally invasive alternative that carries
far fewer risks than traditional approaches but with similar results to
bariatric surgery."
"Revision bariatric procedures are difficult, time consuming and are
associated with high complication rates," according to Dr. Kelvin Higa,
President-Elect, American Society for Bariatric Surgery. With more than
170,000 bariatric procedures estimated to be performed in the US in 2007,
the number of patients requiring a secondary operation will grow as well.
"The need for a less invasive, safer, possibly endoluminal solution to this
problem is of great benefit to our patients. This technology has the
potential to develop into primary bariatric solutions as well," according
to Dr. Higa.
"EndoGastric Solutions is extremely pleased to begin clinical
experience on our second product, StomaphyX," said Thierry Thaure, CEO of
EndoGastric Solutions. "Our mission is to become a full line provider of
transoral surgical devices for pre-cancerous conditions, GERD and obesity.
For many of our customers, this brings the same excitement as when surgical
procedures evolved from open to laparoscopy because now major
reconstructive procedures can be performed completely through natural
orifices and without any incisions."
About EndoGastric Solutions, Inc.
EndoGastric Solutions(TM) is a pioneer in endoluminal procedures for
the treatment of upper gastrointestinal diseases, including GERD and
obesity. EGS's mission is to utilize the most current wisdom in
gastroenterology and surgery to develop new trans-oral procedures and
products to address the largest unmet needs in gastrointestinal diseases.
EGS's initial solutions involve modifying current open surgical and/or
laparoscopic approaches using transoral access. The company designs and
manufactures single use instruments that will enable these incisionless
solutions, and focuses on clinically based products for use by
gastroenterologists and surgeons.
The StomaphyX device is not available for sale or use in the United
States and is currently pending FDA 510(k) clearance. StomaphyX is CE
marked and available in the European Union.
EndoGastric Solutions, Inc.
http://www.endogastricsolutions.com
EndoGastric soluþii, Inc completeazã în totalitate de cinci Transoral refaceþi-obezitate Proceduri: fãrã piele incizie - în cât mai puþin de 20 de minute - EndoGastric Solutions, Inc. Completes Five Fully Transoral Redo-Obesity Procedures: Without Skin Incision - In As Little As 20 Minutes - articole medicale engleza - startsanatate